Ignite Creation Date:
2025-12-26 @ 10:16 PM
Ignite Modification Date:
2025-12-26 @ 10:16 PM
Study NCT ID:
NCT01663012
Status:
COMPLETED
Last Update Posted:
2016-02-24
First Post:
2012-08-02
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
Sponsor:
Lawrence Recht
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-02
First Submit QC Date:
None
Study First Post Date:
2012-08-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-28
Results First Submit QC Date:
None
Results First Post Date:
2015-06-11
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-25
Last Update Post Date:
2016-02-24
Last Update Post Date Type:
ESTIMATED